Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Oxatomide in seasonal rhinoconjunctivitis

C Möller, B Björkstén

|June 1, 1980

Summary

This summary is machine-generated.

A new drug, oxatomide, was tested for severe allergic rhinoconjunctivitis in children. It showed no significant improvement over placebo or existing antihistamines, failing to support its superiority.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Greater Thermal Plasticity Toward Heterogeneous Range-Edge Environments of Three <i>Hypericum</i> Species.

Ecology and evolution·2026

Same author

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils.

Aging brain·2023

Same author

The social, psychological, and physical impact of COVID-19 restrictions for institutionalized adults with intellectual and developmental disabilities.

Journal of intellectual disabilities : JOID·2023

Same author

Propofol sedation in Drug Induced Sedation Endoscopy without an anaesthesiologist â€" a study of safety and feasibility.

Rhinology·2018

Same author

Author Correction: High-temperature operation of electrical injection type-II (GaIn)As/Ga(AsSb)/(GaIn)As "W"-quantum well lasers emitting at 1.3 µm.

Scientific reports·2018

Same author

High-temperature operation of electrical injection type-II (GaIn)As/Ga(AsSb)/(GaIn)As "W"-quantum well lasers emitting at 1.3 µm.

Scientific reports·2018

Area of Science:

Allergy and immunology
Pediatric medicine
Pharmacology

Background:

Allergic seasonal rhinoconjunctivitis significantly impacts children's quality of life.
Previous antihistamine treatments provided insufficient relief for severe cases.

Purpose of the Study:

To evaluate the efficacy of the new antiallergic drug oxatomide.
To compare oxatomide's effectiveness against a combination antihistamine and placebo in children with severe allergic rhinoconjunctivitis.

Main Methods:

A double-blind study was conducted involving 40 schoolchildren.
Participants suffered from severe allergic seasonal rhinoconjunctivitis.
Treatments included oxatomide, cinnarizine with phenylpropanolamine, and placebo.

Related Experiment Videos

Main Results:

No statistically significant difference in therapeutic effect was observed among oxatomide, the antihistamine combination, and placebo.
Oxatomide did not demonstrate superior efficacy compared to the control groups.

Conclusions:

The study does not support the hypothesis that oxatomide is more effective than traditional antihistamine drugs for severe seasonal rhinoconjunctivitis.
Further research may be needed to clarify oxatomide's role in allergy treatment.